Awarded contract

Workflow for NHS Lab delivering SCID Evaluation

Details

Supplier(s)
South West Pathology Services
Value
£59,000
Topic
Blood analysis services
Published
4 March 2024

Tender description

This is a contract for a Lab delivering a service for the ministerially approved Severe Combined Immunodeficiency (SCID) in-service evaluation. This is for the evaluation of the SCID Assay. The contract will end 30th September 2025 Lot 1: This is a contract for a Lab delivering a service for the ministerially approved Severe Combined Immunodeficiency (SCID) in-service evaluation. This is for the evaluation of the SCID Assay

Timeline

  1. Completed: Award date1 March 2024
  2. Completed: Award published4 March 2024
    Current notice

About the buyer

NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.

Clinical services are commissioned directly or through the Provider Selection Regime.

Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.

Relevant CPV codes

  • 85111810 · Blood analysis services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.